BCIQ Profiles

Company Profile ReportTarget Profile Report
0311 AgomAb EMB 2am PT
BioCentury & Getty Images

Emerging Company Profile

AgomAb: antibodies driving tissue regeneration and recovery

Emerging Company Profile: argenx spinout AgomAb raises $74M series B to complete clinical POC for lead mAb and grow pipeline

argenx spinout AgomAb raises Redmile-led $74 million B round to complete clinical POC for lead mAb and grow its pipeline.

Mar 11, 2021 | 10:33 PM GMT

AgomAb parlayed what began as a cancer

Read the full 688 word article

How to gain access

Continue reading with a
two-week free trial.